Evaluating thrombolysis safety in stroke patients who recently took anticoagulants
Official title: Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants: the DOAC - International Thrombolysis (DO-IT) Cohort Study
Run by Insel Gruppe AG, University Hospital Bern · NCT06556446 · Data updated 2026-11-12
This study is testing if giving a clot-busting treatment to stroke patients who recently took blood thinners is safe and helps them recover better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2800 (estimated) |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 33 sites (Innsbruck and 32 other locations) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | March 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | August 16, 2024 |
| Trial ID | NCT06556446 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults diagnosed with acute ischemic stroke who have taken DOACs within the last 48 hours and meet the criteria for IVT.
✕Probably not a fit
Patients with acute or subacute intracranial hemorrhage or those with absolute contraindications to IVT will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This international observational registry aims to assess the safety and effectiveness of intravenous thrombolysis (IVT) in patients with acute ischemic stroke who have recently ingested direct oral anticoagulants (DOACs). The study will involve 2800 adult participants from high-volume stroke centers, divided into three groups: those receiving IVT after DOAC intake, those with DOAC intake not receiving IVT, and a control group without DOACs receiving IVT. Participants will be followed for 90 days post-event to evaluate functional outcomes and the risk of symptomatic intracerebral hemorrhage. The hypothesis is that more liberal use of IVT in these patients may not increase the risk of complications and could improve recovery outcomes.
Why it matters
Potential benefit: If successful, this study could lead to safer treatment protocols for stroke patients on anticoagulants, improving their recovery chances.
How similar studies have gone: While the approach is novel, previous studies have explored thrombolysis in anticoagulated patients, but this specific focus on DOACs is less common.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Clinical diagnosis of acute ischemic stroke with indication for IVT according to applicable guidelines 2. Time from symptom onset or last known well \<12 hours 3. Admission NIHSS of 2 points or more 4. either DOAC ingestion within 48 hours prior to expected timepoint of IVT bolus, or patient with an ongoing prescription of DOAC, but exact timepoint of last intake not verifiable in the emergency setting. (regardless of whether intravenous thrombolysis was given) OR DOAC prescription (any intake within the last 7 days) and receiving intravenous thrombolysis 5. Informed consent (if obtainable and in those international sites where this is legally required) for the prospective part Exclusion Criteria: 1. Patient refused the use of biological data for research purposes (Switzerland) 2. Any acute or subacute intracranial hemorrhage (ICH) identified by admission CT or MRI on brain scan 3. Documentation of any other absolute contraindications to IVT in the medical record 4. Significant pre-stroke disability (mRS score of 5), including known advanced dementia 5. Known (serious) sensitivity to Alteplase/Tenecteplase or any of the excipients 6. Pregnancy or lactating women.
Where it's running
-
Dept. of Medicine, University of Thessaly
Larissa, Thessaly, Greece Recruiting -
Ospedale "Bufalini", Cesena
Perugia, Italy Recruiting -
Clinical Centre of Serbia, University Hospital Belgrade
Belgrade, Serbia Recruiting -
National University Hospital
Singapore, Singapore Recruiting -
Ljubljana University Medical Centre
Ljubljana, Slovenia Recruiting -
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain Recruiting
Show 27 more locations
-
Kantonsspital Aarau
Aarau, Switzerland Recruiting -
Unispital Basel
Basel, Switzerland Recruiting -
Inselspital Bern, University Hospital Bern
Bern, Switzerland Recruiting -
HFR Fribourg
Fribourg, Switzerland Recruiting -
University Hospital Geneva
Geneva, Switzerland Recruiting -
CHUV Lausanne
Lausanne, Switzerland Recruiting -
Kantonsspital Lucerne
Lucerne, Switzerland Recruiting -
EOC Lugano
Lugano, Switzerland Recruiting -
Hôpital Neuchâtelois
Neuchâtel, Switzerland Recruiting -
Kantonsspital St. Gallen
Sankt Gallen, Switzerland Recruiting -
Hirslanden Zurich
Zurich, Switzerland Recruiting -
University Hospital Zurich
Zurich, Switzerland Recruiting -
Medical University of Innsbruck
Innsbruck, Austria Not yet recruiting -
Cliniques Universitaires Saint Luc
Brussels, Belgium Not yet recruiting -
UZ Leuven
Leuven, Belgium Not yet recruiting -
The University of British Columbia | Vancouver General Hospital
Vancouver, Canada Not yet recruiting -
CHU Caen
Caen, France Not yet recruiting -
Nordwest-Krankenhaus Sanderbusch
Sanderbusch, Germany Not yet recruiting -
Universitäsklinikum Tübingen
Tübingen, Germany Not yet recruiting -
A.O.R.N. Antonio Cardarelli Hospital
Naples, Italy Not yet recruiting -
Ospedali Riuniti Hospital
Palermo, Italy Not yet recruiting -
AUSL-IRCCS di Reggio Emilia
Reggio Emilia, Italy Not yet recruiting -
Akershus Hospital
Oslo, Norway Not yet recruiting -
Hospital de Egas Moniz
Lisbon, Portugal Not yet recruiting -
Hospital Universitari de Bellvitge
Barcelona, Spain Not yet recruiting -
Imperial College London NHS Trust
London, United Kingdom Not yet recruiting -
King'S College Hospital Nhs Foundation Trust
London, United Kingdom Not yet recruiting
Study contacts
- Study coordinator: Thomas Meinel, MD, PhD
- Email: thomas.meinel@insel.ch
- Phone: +41 31 66 4 25 67
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
-
Ear-based nerve stimulation to help sleep after a stroke
A device that delivers vagal nerve stimulation through the ear is tested to see if it helps stroke patients in rehab sleep better.
-
Theta Burst Stimulation to Help Stroke Recovery (Upper and Lower Limbs)
This trial tests whether applying theta burst stimulation to the motor cortex, in combination with standard rehabilitation, helps people over 45 who recently had a first ischemic stroke recover arm and leg movement.
-
Preventing another ischemic stroke with a smart bracelet and app
This study tests whether a digital prevention program using a wearable and a mobile app can help people who recently had an ischemic stroke reduce the chance of another stroke and improve risk-factor control.
-
Photon-counting CT to check intracranial stents
This study tests whether ultra-high-resolution photon-counting CT can reliably visualize intracranial stents and detect in-stent restenosis during follow-up of patients with prior stents.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.